ScoreWhy is Astec Lifesciences Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.40 times
- The company has been able to generate a Return on Equity (avg) of 7.84% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 6 consecutive quarters
- OPERATING CF(Y) Lowest at Rs -8.40 Cr
- NET SALES(Q) At Rs 73.72 cr has Fallen at -25.20%
- DPR(Y) Lowest at 0.00%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -29.92%, its profits have fallen by -10%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -29.92% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pesticides & Agrochemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Astec Lifescienc for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Astec Lifescienc
-29.56%
-0.52
57.65%
Sensex
4.41%
0.36
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.95%
EBIT Growth (5y)
-191.72%
EBIT to Interest (avg)
3.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.76
Tax Ratio
15.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.01%
ROCE (avg)
3.10%
ROE (avg)
7.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
31
Price to Book Value
4.35
EV to EBIT
-34.37
EV to EBITDA
-120.65
EV to Capital Employed
2.80
EV to Sales
5.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.14%
ROE (Latest)
-27.53%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
DEBT-EQUITY RATIO(HY)
Lowest at 0.89 times
-10What is not working for the Company
OPERATING CF(Y)
Lowest at Rs -8.40 Cr
NET SALES(Q)
At Rs 73.72 cr has Fallen at -25.20%
DPR(Y)
Lowest at 0.00%
Loading Valuation Snapshot...
Here's what is working for Astec Lifescienc
Debt-Equity Ratio - Half Yearly
Lowest at 0.89 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Astec Lifescienc
Net Sales - Quarterly
At Rs 73.72 cr has Fallen at -25.20%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Operating Cash Flow - Annually
Lowest at Rs -8.40 Cr and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 73.72 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
